A detailed history of Aviva PLC transactions in Lantheus Holdings, Inc. stock. As of the latest transaction made, Aviva PLC holds 6,068 shares of LNTH stock, worth $552,248. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,068
Previous 7,568 19.82%
Holding current value
$552,248
Previous $607,000 9.56%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$77.7 - $123.62 $116,550 - $185,430
-1,500 Reduced 19.82%
6,068 $665,000
Q2 2024

Aug 02, 2024

SELL
$58.87 - $83.05 $143,642 - $202,642
-2,440 Reduced 24.38%
7,568 $607,000
Q1 2024

May 14, 2024

BUY
$51.07 - $68.26 $511,108 - $683,146
10,008 New
10,008 $622,000

Others Institutions Holding LNTH

About Lantheus Holdings, Inc.


  • Ticker LNTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 68,741,904
  • Market Cap $6.26B
  • Description
  • Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...
More about LNTH
Track This Portfolio

Track Aviva PLC Portfolio

Follow Aviva PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aviva PLC, based on Form 13F filings with the SEC.

News

Stay updated on Aviva PLC with notifications on news.